Literature DB >> 10458261

International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury.

M A Shipp1, M D Abeloff, K H Antman, G Carroll, A Hagenbeek, M Loeffler, E Montserrat, J A Radford, G Salles, N Schmitz, M Symann, J O Armitage, T Philip, B Coiffier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10458261     DOI： 10.1200/JCO.1999.17.1.423

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  30 in total

1.  Long-term survival and late-onset complications of cancer patients treated with high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation.

Authors:  K Kohda; S Sakamaki; T Matsunaga; T Kuga; A Fujimi; Y Konuma; T Kusakabe; K Kogawa; T Akiyama; K Koike; Y Hirayama; Y Sasagawa; S Nojiri; Y Hirata; T Nishisato; G Y Niitsu
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

Review 2.  Treatment of aggressive non-Hodgkin's lymphoma with chemotherapy in combination with filgrastim.

Authors:  Jeff Schriber
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Primary diffuse large B-cell lymphoma of the oral cavity: germinal center classification.

Authors:  Indraneel Bhattacharyya; Hardeep K Chehal; Donald M Cohen; Samer Z Al-Quran
Journal:  Head Neck Pathol       Date:  2010-06-09

Review 4.  Randomized trials of high-dose chemotherapy in breast cancer: fraud, the press and the data (or lessons learned in medical policy governing clinical research).

Authors:  Karen Antman
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

5.  Extending the utility of gene profiling data by bridging microarray platforms.

Authors:  Gregory Z Ferl; John M Timmerman; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-08       Impact factor: 11.205

6.  Impact of high-dose chemotherapy and autologous transplantation as first-line therapy on the survival of high-risk diffuse large B cell lymphoma patients: a single-center study in Japan.

Authors:  Shojiro Inano; Makoto Iwasaki; Yoshihiro Iwamoto; Yuki Sueki; Akiko Fukunaga; Soshi Yanagita; Nobuyoshi Arima
Journal:  Int J Hematol       Date:  2013-12-14       Impact factor: 2.490

7.  High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma.

Authors:  Franca Falzetti; Mauro Di Ianni; Stelvio Ballanti; Giuseppe Iodice; Antonia Reale; Olivia Minelli; Gabriella Serio; Massimo F Martelli; Franco Dammacco; Angelo Vacca; Roberto Ria
Journal:  Clin Exp Med       Date:  2011-09-18       Impact factor: 3.984

Review 8.  Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committee.

Authors:  Akshay Sharma; Sherif M Badawy; Elizabeth M Suelzer; Hemant S Murthy; Pinki Prasad; Hesham Eissa; Paul A Carpenter; Mehdi Hamadani; Myriam Labopin; Hélène Schoemans; André Tichelli; Rachel Phelan; Betty K Hamilton; David Buchbinder; Annie Im; Rebecca Hunter; Ruta Brazauskas; Linda J Burns
Journal:  Bone Marrow Transplant       Date:  2021-01-29       Impact factor: 5.483

9.  Prognostic factors in non-Hodgkin's lymphoma patients treated by autologous stem cell transplantation: a single center experience.

Authors:  Cheolwon Suh; Sang Hee Kim; Hyo Jung Kim; Geundoo Jang; Eun Kyung Kim; Ok Bae Ko; Shin Kim; Hee Jung Sohn; Jung Shin Lee; M Wookun Kim; Jooryung Huh
Journal:  Cancer Res Treat       Date:  2005-10-31       Impact factor: 4.679

10.  High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma.

Authors:  Ulrich J M Mey; Vandana Jha; John W Strehl; Marcus Gorschlueter; Christian Rabe; Eckfried Hoebert; Henning Popp; Ingo G H Schmidt-Wolf
Journal:  Ger Med Sci       Date:  2007-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.